HTG Molecular Diagnostics is a life sciences company specializing in advanced molecular profiling technologies that enable researchers and clinicians to analyze gene expression and biomarker signatures efficiently. Its platform supports translational research, precision medicine, and drug development through high-throughput molecular analysis solutions.
Campaign Objective
HTG Molecular Diagnostics partnered with Group Futurista to host a targeted virtual leadership summit designed to:
- Engage senior genomics, research, and clinical innovation leaders
- Showcase the power of gene expression profiling in modern research
- Generate enterprise-qualified demand opportunities
- Position HTG as a trusted authority in molecular diagnostics and translational science
Target Audience Roles
- Chief Scientific Officers
- Genomics Directors
- Clinical Research Leaders
- Translational Medicine Heads
- Laboratory Directors
- Precision Medicine Specialists
- Biotech R&D Executives
Event Metrics
| Metric | Result |
| Total Registrations | 342+ |
| Live Attendance | 43% (approx. 147 attendees) |
| On-Demand Views | 263+ within 30 days |
| Industries Represented | 26 sectors |
| Director Level & Above | 81% |
Event Delivery & Engagement
The summit featured:
- Strategic keynote on advances in molecular profiling technologies
- Expert panel on biomarker discovery and translational applications
- Technical session demonstrating gene expression analysis workflows
- Interactive polling on research and diagnostics priorities
- Live Q&A and structured networking discussions
Engagement Highlights
- Strong participation from genomics and research decision-makers
- 69 audience questions submitted live
- Average viewing duration: 44 minutes
- Peak engagement during biomarker profiling discussion
- Active peer conversations on research innovation strategies
Lead Quality & Conversations Generated
Qualified Leads Delivered: 182 MQLs
Lead Profile
- Biotech firms conducting translational research
- Clinical labs implementing advanced molecular diagnostics
- Pharma organizations exploring biomarker-driven trials
- Research institutions modernizing genomic analysis capabilities
Key Conversation Themes
- Improving biomarker discovery accuracy
- Accelerating translational research timelines
- Enhancing gene expression analysis efficiency
- Integrating molecular data into clinical studies
- Scaling genomic insights across research pipelines
Post-Event Interest Signals
Participants requested:
- Platform demonstrations
- Technical deep-dive sessions
- Research collaboration discussions
- Pilot project evaluations
Results Snapshot
| KPI | Outcome |
| Qualified Leads | 182 |
| Senior Decision Makers | 81% |
| Avg Engagement | 44 mins |
| Questions Asked | 69 |
| Follow-Up Requests | Strong |
| Pipeline Potential | High |
Outcome
Through this focused virtual leadership summit, HTG Molecular Diagnostics successfully:
- Engaged high-intent genomics and research leaders
- Strengthened positioning as a molecular diagnostics innovator
- Generated strong enterprise pipeline opportunities
- Initiated strategic discussions with qualified prospects
- Achieved measurable ROI from a single campaign partnership
